Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
210 people get STE articles and Market Currents by email alert.
Get email alerts on STE »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
-
-
-
-
Business Wire (Oct 31, 2012)
-
-
-
-
3 Rallying Medical Device Stocks With Strong Sources Of ProfitabilityKapitall • Sat, Aug 4, 2012 -
-
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
-
-
3 Rallying Medical Device Stocks With Strong Sources Of ProfitabilityKapitall • Sat, Aug 4, 2012
-
-
-
-
-
-
-
18 Dividend Stocks With Strong Sources Of ProfitabilityKapitall • Wed, Mar 21, 2012
-
Steris Corporation F4Q10 (Qtr End 03/31/10) Earnings Call TranscriptSat, May 8, 2010
-
STERIS Corporation F3Q09 (Qtr End 12/31/08) Earnings Call TranscriptTue, Jan 27, 2009
-
Steris Corporation F2Q09 (Qtr End 09/30/08) Earnings Call TranscriptMon, Nov 3, 2008
-
Steris Corporation F4Q08 (Qtr End 03/31/08) Earnings Call TranscriptTue, May 13, 2008
-
Steris Corp. F3Q08 (Qtr End 12/31/07) Earnings Call TranscriptThu, Jan 31, 2008
-
Business Wire (Oct 31, 2012)
-
at CNBC.com (Oct 21, 2011)
STE vs. ETF Alternatives
Company Description
Currently, there's no company description for STE.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, May 7, 11:49 AM Steris (STE +8.4%) climbs sharply higher after earnings beat estimates for both FQ4 and FY13 ($2.34 per share versus consensus of $2.30). On a segment-by-segment basis, Healthcare consumables and services saw revenue growth of 42% and 29% respectively, while capital equipment sales growth was flat. In Life Sciences, capital equipment, service, and consumable revenues grew 13%, 8%, and 6% respectively. The company sees revenue growth of 8-10% in FY14 and EPS of $2.47-2.60 versus consensus of $2.49. (PR) Comment! [Healthcare, Earnings, On the Move]
- Tuesday, May 7, 7:29 AM Steris (STE): Q1 EPS of $0.70 beats by $0.06. Revenue of $426.2M beats by $20.41M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Wednesday, February 6, 7:25 AM Steris (STE): FQ3 EPS of $0.58 beats by $0.02. Revenue of $380.4M (+7% Y/Y) beats by $12M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Wednesday, October 31, 2012, 7:27 AM Steris (STE): FQ2 EPS of $0.53 beats by $0.01. Revenue of $356.3M (-2% Y/Y) beats by $6M. (PR) Comment! [Earnings, Healthcare]
- Thursday, August 2, 2012, 7:32 PM Steris (STE): FQ1 EPS of $0.53 beats by $0.09. Revenue of $337M (+5.8% Y/Y) beats by $15.1M. (PR) Comment! [Earnings, Healthcare]
- Tuesday, May 8, 2012, 8:49 AM Steris (STE): Q1 EPS of $0.59 may not be comparable to consensus of $0.60. Revenue of $390M (-0.8% Y/Y) beats by $10M. (PR) Comment! [Earnings, Healthcare]
- Tuesday, February 7, 2012, 8:53 AM Steris (STE): FQ3 EPS of $0.58 may not be comparable to consensus of $0.60. Revenue of $355.2M (+8.2% Y/Y). (PR) Comment! [Earnings, Healthcare]
-
Jim Van Meerten
$STE - 100% Barchart technical buy signals - 7 new hghs and up 6.88% in the last month - Relative Strength Index 69.78% - View all 0 replies
-
Jim Van Meerten
STE - 96% Barchart technical buy signal - 12 new highs and up 5.10% in the last month - Relative Strength Index 73.24% - View all 0 replies
-
Jim Van Meerten
STE - Streis-80% Barchart.com technical sell signal-Trdainf below 20 & 50 day moving average-Relative Strength Index 41.19% and falling - View all 0 replies
-
Jim Van Meerten
STE - Steris - 96% Barchart technical buy signal - 16 new highs and up 12.21% in the last month - Relative strength Index 72.59% and rising - View all 0 replies
-
- View all 0 replies
LATEST REPLIES